Bicheng Wang1 article listing Bicheng Wang in Nature Communications, indexed by Paperzzz from Crossref and OSF.Stereotactic body radiotherapy with sintilimab and bevacizumab biosimilar in anti-PD-1 refractory hepatocellular carcinoma: the ReUNION-1 phase 2 trial Nature Communications